DEKABANK DEUTSCHE GIROZENTRALE – Regeneron Pharmaceuticals, Inc. Transaction History
DEKABANK DEUTSCHE GIROZENTRALE portfolio value:
$122.92M
portfolio value
DEKABANK DEUTSCHE GIROZENTRALE quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.47% | 7.65K shares | 20.92M | $688.87 | 178.87K |
| Q2 2022 | share | Increase | +13.40% | 20.22K shares | -3.51M | $591.13 | 171.21K |
| Q1 2022 | share | Increase | +43.05% | 45.44K shares | 37.28M | $698.42 | 150.98K |
| Q4 2021 | share | Increase | +9.35% | 9.02K shares | 9.08M | $642.51 | 105.54K |
| Q3 2021 | share | Increase | +15.27% | 12.78K shares | 13.45M | $605.18 | 96.51K |
| Q2 2021 | share | Increase | +6.11% | 4.81K shares | 8.54M | $558.54 | 83.73K |
| Q1 2021 | share | Increase | +30.90% | 18.62K shares | 7.85M | $473.14 | 78.91K |
| Q4 2020 | share | Increase | +22.09% | 10.90K shares | -40K | $483.11 | 60.28K |
| Q3 2020 | share | Increase | +276.61% | 36.26K shares | 21.30M | $559.78 | 49.37K |
| Q2 2020 | share | Increase | +13.60% | 1.57K shares | 2.47M | $623.65 | 13.11K |
| Q1 2020 | share | Increase | +0.38% | 44 shares | 1.28M | $488.29 | 11.54K |
| Q4 2019 | share | Decrease | -76.55% | -37.53K shares | -9.20M | $375.48 | 11.49K |
| Q3 2019 | share | Decrease | -17.84% | -10.64K shares | -5.15M | $277.4 | 49.02K |
| Q2 2019 | share | Increase | +26.48% | 12.49K shares | -762K | $313 | 59.67K |
| Q1 2019 | share | Increase | +21.02% | 8.19K shares | 5.08M | $410.62 | 47.17K |
| Q4 2018 | share | Decrease | -17.37% | -8.19K shares | -5.08M | $373.5 | 38.98K |
| Q3 2018 | share | Decrease | -24.06% | -14.95K shares | -1.94M | $404.04 | 47.17K |
| Q2 2018 | share | Increase | +31.81% | 14.99K shares | 5.23M | $344.99 | 62.12K |
| Q1 2018 | share | Decrease | -33.21% | -23.43K shares | -17.09M | $344.36 | 47.13K |
| Q4 2017 | share | Increase | +0.64% | 450 shares | 212K | $375.96 | 70.56K |
| Q3 2017 | share | Decrease | -6.73% | -5.05K shares | -5.41M | $447.12 | 70.11K |
| Q2 2017 | share | Increase | +8.72% | 6.02K shares | 11.61M | $491.14 | 75.17K |
| Q1 2017 | share | Increase | +0.80% | 547 shares | 812K | $387.51 | 69.14K |
| Q4 2016 | share | Increase | +3.45% | 2.28K shares | -961K | $367.09 | 68.6K |
| Q3 2016 | share | Increase | +2.78% | 1.79K shares | 4.48M | $402.02 | 66.31K |
| Q2 2016 | share | Increase | +0.15% | 97 shares | -720K | $349.23 | 64.51K |
| Q1 2016 | share | Decrease | -9.45% | -6.72K shares | -15.83M | $360.44 | 64.42K |